The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Depression rating scales in Parkinson's disease: Critique and recommendations
Open accessAbstract
Depression is a common comorbid condition in Parkinson's disease (PD) and a major contributor to poor quality of life and disability. However, depression can be difficult to assess in patients with PD due to overlapping symptoms and difficulties in the assessment of depression in cognitively impaired patients. As several rating scales have been used to assess depression in PD (dPD), the Movement Disorder Society commissioned a task force to assess their clinimetric properties and make clinical recommendations regarding their use. A systematic literature review was conducted to explore the use of depression scales in PD and determine which scales should be selected for this review. The scales reviewed were the Beck Depression Inventory (BDI), Hamilton Depression Scale (Ham‐D), Hospital Anxiety and Depression Scale (HADS), Zung Self‐Rating Depression Scale (SDS), Geriatric Depression Scale (GDS), Montgomery‐Asberg Depression Rating Scale (MADRS), Unified Parkinson's Disease Rating Scale (UPDRS) Part I, Cornell Scale for the Assessment of Depression in Dementia (CSDD), and the Center for Epidemiologic Studies Depression Scale (CES‐D). Seven clinical researchers with clinical and research experience in the assessment of dPD were assigned to review the scales using a structured format. The most appropriate scale is dependent on the clinical or research goal. However, observer‐rated scales are preferred if the study or clinical situation permits. For screening purposes, the HAM‐D, BDI, HADS, MADRS, and GDS are valid in dPD. The CES‐D and CSDD are alternative instruments that need validation in dPD. For measurement of severity of depressive symptoms, the Ham‐D, MADRS, BDI, and SDS scales are recommended. Further studies are needed to validate the CSDD, which could be particularly useful for the assessment of severity of dPD in patients with comorbid dementia. To account for overlapping motor and nonmotor symptoms of depression, adjusted instrument cutoff scores may be needed for dPD, and scales to assess severity of motor symptoms (e.g., UPDRS) should also be included to help adjust for confounding factors. The HADS and the GDS include limited motor symptom assessment and may, therefore, be most useful in rating depression severity across a range of PD severity; however, these scales appear insensitive in severe depression. The complex and time‐consuming task of developing a new scale to measure depression specifically for patients with PD is currently not warranted. © 2007 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813
Cited by
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Self-citationParkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis
Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevsky, J., Burn, D., Barone, P., Pagonabarraga, J., Allcock, L., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f39d0e · Cited by 748
Self-citationCognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., & Alves, G. (2009) · Neurology · doi:10.1212/01.wnl.0000338632.00552.cb · Cited by 625
Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression
Fereshtehnejad, S.-M., Zeighami, Y., Dagher, A., & Postuma, R. B. (2017) · Brain · doi:10.1093/brain/awx118 · Cited by 613
Depression in Parkinson disease—epidemiology, mechanisms and management
Aarsland, D., Påhlhagen, S., Ballard, C. G., Ehrt, U., & Svenningsson, P. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.189 · Cited by 593
Barone, P., Poewe, W., Albrecht, S., Debieuvre, C., Massey, D., Rascol, O., Tolosa, E., & Weintraub, D. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70106-x · Cited by 562
Self-citationNeuropsychiatric symptoms in Parkinson's disease
Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 557
Self-citationApathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment
Pagonabarraga, J., Kulisevsky, J., Strafella, A. P., & Krack, P. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00019-8 · Cited by 549
Mhyre, T. R., Boyd, J. T., Hamill, R. W., & Maguire-Zeiss, K. A. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-5416-4_16 · Cited by 423
Parkinson's disease: The quintessential neuropsychiatric disorder
Weintraub, D., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23664 · Cited by 423
Self-citationLord, S., Galna, B., Verghese, J., Coleman, S., Burn, D., & Rochester, L. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls255 · Cited by 412
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
Duncan, G. W., Khoo, T. K., Yarnall, A. J., O'Brien, J. T., Coleman, S. Y., Brooks, D. J., Barker, R. A., & Burn, D. J. (2014) · Movement Disorders · doi:10.1002/mds.25664 · Cited by 382
Emotional stimuli and motor conversion disorder
Voon, V., Brezing, C., Gallea, C., Ameli, R., Roelofs, K., LaFrance, W. C., & Hallett, M. (2010) · Brain · doi:10.1093/brain/awq054 · Cited by 353
Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations
Leentjens, A. F. G., Dujardin, K., Marsh, L., Martinez‐Martin, P., Richard, I. H., Starkstein, S. E., Weintraub, D., Sampaio, C., Poewe, W., Rascol, O., et al. (2008) · Movement Disorders · doi:10.1002/mds.22229 · Cited by 346
Self-citationPrognosis of Mild Cognitive Impairment in Early Parkinson Disease: The Norwegian ParkWest Study
Pedersen, K. F., Larsen, J. P., Tysnes, O.-B., & Alves, G. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2110 · Cited by 315
Bloem, B. R., Marinus, J., Almeida, Q., Dibble, L., Nieuwboer, A., Post, B., Ruzicka, E., Goetz, C., Stebbins, G., Martinez‐Martin, P., et al. (2016) · Movement Disorders · doi:10.1002/mds.26572 · Cited by 314
Self-citationCognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., Bienfait, K. L., & Friedman, J. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111669 · Cited by 310
Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations
Martinez‐Martin, P., Jeukens‐Visser, M., Lyons, K. E., Rodriguez‐Blazquez, C., Selai, C., Siderowf, A., Welsh, M., Poewe, W., Rascol, O., Sampaio, C., et al. (2011) · Movement Disorders · doi:10.1002/mds.23834 · Cited by 308
Self-citationAnxiety rating scales in Parkinson's disease: Critique and recommendations
Leentjens, A. F. G., Dujardin, K., Marsh, L., Martinez‐Martin, P., Richard, I. H., Starkstein, S. E., Weintraub, D., Sampaio, C., Poewe, W., Rascol, O., et al. (2008) · Movement Disorders · doi:10.1002/mds.22233 · Cited by 275
Self-citationDevos, D., Dujardin, K., Poirot, I., Moreau, C., Cottencin, O., Thomas, P., Destée, A., Bordet, R., & Defebvre, L. (2008) · Movement Disorders · doi:10.1002/mds.21966 · Cited by 274
Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations
Högl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B., Trenkwalder, C., Poewe, W., Rascol, O., Sampaio, C., et al. (2010) · Movement Disorders · doi:10.1002/mds.23190 · Cited by 268
Self-citationNatural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study
Pedersen, K. F., Larsen, J. P., Tysnes, O.-B., & Alves, G. (2017) · Neurology · doi:10.1212/wnl.0000000000003634 · Cited by 267
Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease
Ballanger, B., Strafella, A. P., van Eimeren, T., Zurowski, M., Rusjan, P. M., Houle, S., & Fox, S. H. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.35 · Cited by 266
Rios Romenets, S., Anang, J., Fereshtehnejad, S.-M., Pelletier, A., & Postuma, R. (2015) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2015.01.015 · Cited by 265
Identification of blood microRNAs associated to Parkinsońs disease
Margis, R., Margis, R., & Rieder, C. R. M. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.01.023 · Cited by 263
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait
Tessitore, A., Amboni, M., Esposito, F., Russo, A., Picillo, M., Marcuccio, L., Pellecchia, M. T., Vitale, C., Cirillo, M., Tedeschi, G., et al. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.03.018 · Cited by 257
Self-citationFriedman, J. H., Alves, G., Hagell, P., Marinus, J., Marsh, L., Martinez‐Martin, P., Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., et al. (2010) · Movement Disorders · doi:10.1002/mds.22989 · Cited by 257
Self-citationGodinho, C., Domingos, J., Cunha, G., Santos, A. T., Fernandes, R. M., Abreu, D., Gonçalves, N., Matthews, H., Isaacs, T., Duffen, J., et al. (2016) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-016-0136-7 · Cited by 226
Cruise, K. E., Bucks, R. S., Loftus, A. M., Newton, R. U., Pegoraro, R., & Thomas, M. G. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01338.x · Cited by 229
Psychosis, apathy, depression and anxiety in Parkinson's disease
Gallagher, D. A., & Schrag, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.041 · Cited by 211
Self-citationSymptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study
Leentjens, A. F. G., Dujardin, K., Marsh, L., Martinez‐Martin, P., Richard, I. H., & Starkstein, S. E. (2011) · Movement Disorders · doi:10.1002/mds.23528 · Cited by 173
Self-citationRios Romenets, S., Creti, L., Fichten, C., Bailes, S., Libman, E., Pelletier, A., & Postuma, R. B. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.03.003 · Cited by 166
Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease
Balestrino, R., & Martinez-Martin, P. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.12.060 · Cited by 135
A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease
Papapetropoulos, S., Katzen, H., Schrag, A., Singer, C., Scanlon, B. K., Nation, D., Guevara, A., & Levin, B. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-21 · Cited by 111
Self-citationGeneralized anxiety disorder and the Hamilton anxiety rating scale in Parkinson's disease
Kummer, A., Cardoso, F., & Teixeira, A. L. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000400005 · Cited by 103
Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease
Rodriguez‐Blazquez, C., Frades‐Payo, B., Forjaz, M. J., de Pedro‐Cuesta, J., Martinez‐Martin, P., & on behalf of the Longitudinal Parkinson's Disease Patient Study (Estudio longitudinal de pacientes con enfermedad de Parkinson ‐ELEP) Group (2009) · Movement Disorders · doi:10.1002/mds.22321 · Cited by 97
Anxiety, depression, and quality of life in Parkinson's disease
Quelhas, R., & Costa, M. (2009) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.2009.21.4.413 · Cited by 100
Telephone-Based Cognitive–Behavioral Therapy for Depression in Parkinson Disease
Dobkin, R. D., Menza, M., Allen, L. A., Tiu, J., Friedman, J., Bienfait, K. L., Gara, M. A., & Mark, M. H. (2011) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988711422529 · Cited by 88
Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease
Pachana, N. A., Egan, S. J., Laidlaw, K., Dissanayaka, N., Byrne, G. J., Brockman, S., Marsh, R., & Starkstein, S. (2013) · Movement Disorders · doi:10.1002/mds.25689 · Cited by 82
Self-citationTong, Q., Zhang, L., Yuan, Y., Jiang, S., Zhang, R., Xu, Q., Ding, J., Li, D., Zhou, X., & Zhang, K. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.05.016 · Cited by 81
Mills, K. A., Greene, M. C., Dezube, R., Goodson, C., Karmarkar, T., & Pontone, G. M. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4834 · Cited by 63
Cognitive-Behavioral Therapy for Anxiety in Parkinson’s Disease
Reynolds, G. O., Saint-Hilaire, M., Thomas, C. A., Barlow, D. H., & Cronin-Golomb, A. (2020) · Behavior Modification · doi:10.1177/0145445519838828 · Cited by 59
Know thyself: Exploring interoceptive sensitivity in Parkinson's disease
Ricciardi, L., Ferrazzano, G., Demartini, B., Morgante, F., Erro, R., Ganos, C., Bhatia, K. P., Berardelli, A., & Edwards, M. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.03.019 · Cited by 46
Anhedonia and its correlation with clinical aspects in Parkinson’s disease
Nagayama, H., Maeda, T., Uchiyama, T., Hashimoto, M., Nomoto, N., Kano, O., Takahashi, T., Terashi, H., Hamada, S., Hasegawa, T., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.10.051 · Cited by 33
Zhang, P., Huang, P., Li, Y., Du, J., Luo, N., He, Y., Liu, J., He, G., Cui, S., Zhang, W., et al. (2024) · Aging and disease · doi:10.14336/ad.2023.0518 · Cited by 30
The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease
Charidimou, A., Seamons, J., Selai, C., & Schrag, A. (2011) · Parkinson's Disease · doi:10.4061/2011/737523 · Cited by 22
Self-citation“Pseudo-syndromes” associated with Parkinson disease, dementia, apathy, anxiety, and depression
Weiss, H. D., & Pontone, G. M. (2019) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000644 · Cited by 21
Metadata
- Authors
- Schrag, A., Barone, P., Brown, R. G., Leentjens, A. F. G., McDonald, W. M., Starkstein, S., Weintraub, D., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., & Goetz, C. G.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2007-06-15
- Volume
- 22
- Issue
- 8
- Pages
- 1077-1092
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2063956606
- Cited by
- 683
- References
- 185
- FWCI
- 19.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.